Clinical characteristics of TAO group
| Gender | Age | Proptosis (Keeler exophthalmometry/mm) in biopsied orbit | CAS score | TAO treatment | Graves' disease (GD) status at time of biopsy |
| M | 77 | 23 | 2 | N | Known GD. Controlled with carbimazole |
| F | 45 | 22 | 1 | N | Active GD, controlled with carbimazole |
| F | 38 | 22 | 2 | N | Active GD, controlled with carbimazole |
| F | 44 | 21 | 2 | N | TFTs normal, GD diagnosed 6 months after biopsy |
| F | 52 | 23 | 1 | N | Active GD, controlled with carbimazole |
CAS, clinical activity score; TAO, thyroid-associated orbitopathy; TFT, thyroid function tests.